Dow Jones futures edged lower overnight, along with S&P 500 futures and Nasdaq futures.The stock market rally was mixed but ...

Oregon Attorney General Dan Rayfield filed a $900 million lawsuit against the nation's largest insulin manufacturers, ...

After market close on Wednesday, U.S. pharmaceutical giant Eli Lilly (LLY) confirmed its plan to acquire Ventyx Biosciences (VTYX) for approximately $1.2 billion, further expanding its pipeline ...

The biotech is developing drugs that target the biology of aging to treat obesity, cardiovascular disease, and more ...

Oregon is joining cities, unions, and states across the country that have filed lawsuits alleging pharmacy benefit mangers ...

Jan 7 (Reuters) - Eli Lilly ‌will ​buy autoimmune drug developer ‌Ventyx Biosciences for $1.2 billion in cash, the companies ...

Pharma stocks are back in focus as obesity drugs, HIV prevention and biotech deal activity shape the outlook heading into ...

Viking Therapeutics announced its new Chief Commercial Officer, Neil Aubuchon, on Jan. 7, 2026. Viking is a clinical-stage ...

Arrowhead’s RNA drugs could aid with “high-quality” weight loss, according to one analyst. Elsewhere, the PD-1/VEGF field got ...

Cancer drug developer Aktis Oncology said on Wednesday it was targeting a valuation of up to $945.4 million in its upsized ...

Eli Lilly shares surged over 4.5% on analyst upgrades, acquisition rumors involving Ventyx Biosciences, and a new $1.3 ...